Update On Active Movers: Lipocine (LPCN), International Consolidated (NCC), Vapor Group Inc (VPOR)

Posted In Business - By Sheryl Sternberg On Wednesday, September 24th, 2014 With 0 Comments

Dallas, Texas 09/24/2014 (ustradevoice) – Lipocine Inc (NASDAQ:LPCN) said its Phase 3 clinical study of LPCN 1021 was successful. It said the trial met the primary endpoint and managed to restore testosterone levels to the required range in 88% of the patients tested. Shares of the $69 million company gapped up more than 45% in the early afternoon Wednesday because of the positive study report. Lipocine Inc (NASDAQ:LPCN) intends to seek approval for the commercialization of the drug in the latter half of 2015. Lipocine Inc (NASDAQ:LPCN) is also working on another testosterone product. Low testosterone leads to symptoms such as loss of muscle mass, depression and loss of libido.

There was very little to keep investors clued in International Consolidated Companies Inc (OTCMKTS:INCC). They headed for the exit door and left the stock tumbling more than 4% in the early afternoon Wednesday. That happened even as the $67 million company recently announced its desire to be SEC reporting and compliant. Towards that end, International Consolidated Companies Inc (OTCMKTS:INCC) tapped ZBS Group, LLP, as its auditor. The certified public accountants and advisors would look into its financial statements, and once the auditing job is concluded, they will make SEC Form 10 filing. That development will put International Consolidated Companies Inc (OTCMKTS:INCC) on the path to becoming a fully reporting public company, which is important for its profile and shareholders.

Vapor Group Inc (OTCMKTS:VPOR)‘s financial health is improving, and the company cannot wait but make hay while the sun shines. At least in the sense that it wants to reduce its debt burden while it still has money to for that. Vapor Group Inc (OTCMKTS:VPOR) announced that it would pay down part of the more than $1 million convertible notes with interest rate of 8% that it issued to Hanover Holdings. The company reached out to Hanover for financing at a critical moment when it was facing burgeoning demand for its products, yet its capacity was stretched to the limits, making it impossible to meet the demand.

About the Author

- Sheryl Sternberg is very passionate about her work. She has earned a reputation in the Tampa Bay area for landing interviews with some of the area's biggest and most controversial newsvmakers. She has also received numerous awards from the Associated Press, Society of Professional Journalists, and other media organizations for many of her exclusive stories. In addition to her three Emmys, Sheryl Sternberg has been nominated for four additional awards.

Leave a comment

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Register for FREE to finish reading this article. 240,606 investors already registered.

Register now to access the entire article and receive a featured newsletter from our official content provider; PennyStockTweeters.com.